Ticagrelor Monotherapy in Patients at High Bleeding Risk Undergoing PCI
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Ticagrelor monotherapy in patients at high bleeding risk undergoing percutaneous coronary intervention: TWILIGHT-HBR
Eur Heart J 2021 Oct 18;[EPub Ahead of Print], J Escaned, D Cao, U Baber, J Nicolas, S Sartori, Z Zhang, G Dangas, DJ Angiolillo, C Briguori, DJ Cohen, T Collier, D Dudek, M Gibson, R Gil, K Huber, U Kaul, R Kornowski, MW Krucoff, V Kunadian, S Mehta, DJ Moliterno, EM Ohman, KG Oldroyd, G Sardella, SK Sharma, R Shlofmitz, G Weisz, B Witzenbichler, S Pocock, R MehranFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.